BofA Securities downgrades Nutrien stock to Neutral on fertilizer price concerns

BofA Securities downgraded Nutrien (NTR) to Neutral from Buy, setting a $67.00 price target, citing a decelerating fertilizer price rally, fair valuation following a 38% year-to-date stock increase, and ongoing agricultural cycle concerns. This downgrade follows Nutrien's Q2 2025 earnings, which saw an EPS beat at $2.65 but a revenue miss at $10.44 billion, alongside the announcement of a $600 million sale of its 50% stake in Profertil S.A. The company faces divergent analyst sentiment, with JPMorgan upgrading to Overweight while Jefferies maintained a Hold rating with a reduced price target.

Analysis

BofA Securities downgraded Nutrien (NTR) from Buy to Neutral, setting a $67.00 price target, primarily citing concerns over weakening fertilizer prices, particularly in ammonia and potash markets. This re-rating follows a significant 37.75% year-to-date stock surge, bringing NTR's valuation to an estimated 7 times BofA’s projected 2026 EBITDA, which the firm now considers fair. Persistent concerns regarding the agricultural cycle also contributed to the revised, more balanced risk/reward assessment.

Nutrien's Q2 2025 earnings presented a mixed picture, with an EPS beat of $2.65 against forecasts of $2.39, but a revenue miss at $10.44 billion compared to the anticipated $10.55 billion. Concurrently, the company announced the strategic divestiture of its 50% stake in Argentine nitrogen producer Profertil S.A. for approximately $600 million, a transaction expected to finalize by year-end 2025. This move signals a focus on portfolio optimization amid evolving market conditions.

Analyst sentiment remains bifurcated, reflecting the complex outlook for NTR. While JPMorgan upgraded the stock to Overweight with a $68.00 price target, citing favorable fertilizer market conditions, Jefferies maintained a Hold rating and lowered its price target to $60.00, referencing the Profertil sale and a mixed outlook. The stock currently trades near its 52-week high of $65.08, indicating that much of the positive sentiment from earlier in the year may already be priced in.

Key Decisions for Investors

• Monitor fertilizer commodity price trends, especially ammonia and potash, as BofA's downgrade is heavily predicated on their weakening momentum.
• Evaluate Nutrien's valuation relative to its peers and historical multiples, considering the significant year-to-date stock appreciation and BofA's fair valuation assessment.
• Assess the long-term implications of the Profertil S.A. divestiture on Nutrien's strategic focus and capital allocation, particularly how the $600 million proceeds will be utilized.
• Watch for further analyst revisions and company guidance, as current sentiment is mixed, reflecting uncertainty in the agricultural cycle and commodity markets.